METHODS:
This interventional case series comprised 11 eyes of 10 aphakic patients without capsular support undergoing retropupillary fi xation of the Verisyse, and 21 eyes of 20 patients undergoing transscleral suturing fi xation of foldable acrylic IOLs (15 eyes of 14 patients, SuperFlex620H [Rayner Intraocular Lenses Ltd]) and polymethylmethacrylate IOLs (6 eyes of 6 patients, CP60NS [CORNEAL Laboratoire]). Surgical time was measured. Corrected distance visual acuity (CDVA) and intraocular pressure (IOP) were examined preoperatively and 1 day, 1 and 2 weeks, and 1 and 6 months postoperatively.
RESULTS:
No complications occurred in the Verisyse group, whereas complications were reported in seven eyes in the transscleral suturing fi xation group throughout follow-up. Mean CDVA (logMAR) in the transscleral suturing group 1 day after surgery was signifi cantly worse than preoperative CDVA (PϽ.05). In the Verisyse group, no signifi cant changes in CDVA were noted at any time point. Mean IOP at postoperative day 1 in the transscleral suturing fi xation group was signifi cantly higher than that in the Verisyse group (P=.0126). Mean surgical time of Verisyse implantation (20.0Ϯ8.9 min) was signifi cantly shorter than transscleral suturing fi xation (49.7Ϯ18.9 min) (PϽ.0001).
CONCLUSIONS: Retropupillary fi xation of an iris-claw IOL provides early visual recovery, has a low risk of postoperative increase in IOP, and is a time-saving method compared with transscleral suturing fi xation for aphakic eyes without suffi cient capsular support. S everal surgical methods of intraocular lens (IOL) implantation for eyes without suffi cient capsular support have been developed. Angle-fi xated anterior chamber IOL implantation is one therapeutic option and has technical advantages such as ease and minimal invasion during the surgery. However, several complications such as progressive damage of corneal endothelial cells, decompensation, chronic infl ammation in the anterior chamber, secondary glaucoma, and cystoid macular edema have been reported. [1] [2] [3] [4] [5] [6] Implantation of an iris-claw-fi xated anterior chamber IOL is another method. Early generations of iris-claw anterior chamber IOLs lacked adequate space between the IOL and iris or corneal endothelial cells, which can lead to damage to the iris or corneal endothelial cells. [7] [8] [9] Later generations of iris-claw-fi xated anterior chamber IOLs (Verisyse; Abbott Medical Optics, Santa Ana, California) were developed with a vaulted optic design, which can provide enough space for aqueous fl ow between the IOL and iris to avoid iris chafi ng. Because the Verisyse lens was originally designed for surgical correction of phakic myopic eyes and the haptics are enclavated to the mid-peripheral iris stroma, it barely interferes with physiological movement of the pupil. This new design can reduce dispersion of iris pigment epithelium that can cause chronic ocular infl ammation.
Previous studies have reported the effi cacy of Verisyse IOL implantation in the anterior chamber for correction of refractive error in aphakic eyes without adequate capsular support. [10] [11] [12] [13] However, Verisyse IOL implantation in the anterior Iris-claw IOL Fixation Without Capsular Support/Hara et al chamber may cause damage to the corneal endothelial cells. Güell et al 12 reported a mean 10.9% endothelial cell loss during the fi rst 36 months after Verisyse implantation in the anterior chamber. Furthermore, to maintain the physiological features of an open-angled anterior chamber, it is desirable to implant the IOL in the posterior chamber with adequate distance from the corneal endothelium to avoid progressive corneal endothelial cell loss. For these reasons, the transscleral posterior chamber IOL suturing technique is favored by many surgeons as a method of posterior chamber IOL fi xation at the ciliary sulcus for eyes without suffi cient capsular support. [14] [15] [16] [17] In contrast, there have been various reports regarding the complications associated with transscleral suturing fi xation, such as ciliary choroidal body hemorrhage, vitreous prolapse into the anterior chamber, retinal detachment, IOL dislocation, uveitis, cystoid macular edema, and conjunctival erosion. [18] [19] [20] [21] Although the technique of transscleral suturing fi xation has been improved to reduce those risks associated with the surgery, most of these techniques are still complex and invasive and require extensive experience to be performed safely and in a short time period. [14] [15] [16] [17] 22 Retropupillary fi xation of a Verisyse IOL in the posterior chamber is expected to be a less invasive and safer method of posterior chamber IOL implantation for aphakic eyes without suffi cient capsular support. [23] [24] [25] [26] [27] Although Menezo et al 21 previously compared the visual outcomes and complications between implantation of an iris-fi xated anterior chamber IOL (Worst-type) and transscleral suturing fi xation of a posterior chamber IOL for aphakic eyes without suffi cient capsular support, the present study is the fi rst report to compare the safety and visual recovery between retropupillary fi xation of a Verisyse IOL in the posterior chamber and transscleral suturing fi xation of a posterior chamber IOL for aphakic eyes with insufficient capsular support.
PATIENTS AND METHODS
This prospective, interventional case series comprised 32 eyes of 30 patients with ages ranging from 18 to 88 years who presented at the International Vision Correction Research Centre, University of Heidelberg for secondary IOL implantation. Inclusion criteria were eyes that had already undergone lens extraction and resulted in aphakia with absence of suffi cient capsular support.
The secondary IOL implantation was performed by a single surgeon (G.U.A.) in all eyes. Eleven eyes of 10 patients (mean age: 62.2Ϯ25.5 years; range: 18 to 88 years) underwent retropupillary fi xation of the Verisyse lens, which is an iris-claw, biconvex, polymethylmethacrylate (PMMA) IOL with an 8.5-mm length, 0.95-mm maximum height, and 5.0-mm optical zone. Fifteen eyes of 14 patients (mean age: 63.9Ϯ18.1 years; range: 18 to 86 years) underwent implantation of a foldable hydrophilic acrylic posterior chamber IOL (SuperFlex620H; Rayner Intraocular Lenses Ltd, East Sussex, United Kingdom) with an optic diameter of 6.25 mm and overall length of 12.5 mm by transscleral suturing fi xation. Six eyes of 6 patients (mean age: 60.7Ϯ24.0 years; range: 18 to 86 years) underwent implantation of an unfoldable PMMA posterior chamber IOL (CP60NS; CORNEAL Laboratoire, Paris, France) with an optic diameter of 6.0 mm and overall length of 13.5 mm by transscleral suturing fi xation. The surgical methods and IOLs were chosen randomly according to a computer-generated list.
Before the present study was started, the surgeon had performed both procedures more than 20 times Iris-claw IOL Fixation Without Capsular Support/Hara et al and was therefore familiar with both retropupillary fi xation and the transscleral suturing technique. Backgrounds of the absent suffi cient capsular support are shown in Table 1 . The study protocol adhered to the tenets of the Declaration of Helsinki, and full written informed consent was obtained from all patients. Corrected distance visual acuity (CDVA) as well as intraocular pressure (IOP) were examined preoperatively and at 1 day, 1 and 2 weeks, and 1 and 6 months postoperatively. Postoperative complications and replacement of IOLs due to dislocations were also investigated. The difference in mean surgical time between the two procedures was analyzed statistically.
STATISTICAL ANALYSIS
StatView software (Windows 2000; SAS Institute Inc, Cary, North Carolina) was used for statistical analysis. One-way analysis of variance (ANOVA) was performed to study the statistical signifi cance of the differences in CDVA preoperatively and at each postoperative follow-up. Non-paired t tests were used to study the statistical signifi cance of the differences in mean IOP at each measurement period between the two methods of IOL implantation. Non-paired t tests were applied to evaluate the differences in the surgical time between the two methods of IOL implantation. P values Ͻ.05 were considered statistically signifi cant.
SURGICAL PROCEDURE
Retropupillary Fixation of the Verisyse IOL. Two vertical paracentral paracenteses at the 3-and 9-o'clock positions were performed followed by an injection of cohesive viscoelastic material (sodium hyaluronate 1%) into the anterior chamber to protect the corneal endothelium and behind the iris plane to obtain and maintain enough space to manipulate the IOL. Scleral tunnel incisions of 5-to 6-mm widths at the 12-o'clock position were created. Bimanual anterior vitrectomy through the paracentesis and the scleral tunnel incision was performed only when vitreous prolapse into the anterior chamber was observed. A Verisyse IOL was inserted through the scleral tunnel into the anterior chamber with the vaulting optic leading posteriorly. The iris-claw haptics were rotated with a hook, keeping a horizontal position until at the 3-9-o'clock position. After aiming at a fi xating position, a lens fi xation forceps was introduced through the scleral tunnel to grasp the center of the optic tightly and horizontally, remaining centered to the pupil. One of two haptics was placed behind the iris through the pupil and was enclaved at the aimed retropupillary position by pushing the iris with a phacoemulsifi cation spatula from the anterior chamber, entrapping the iris through the slotted center of the haptic. The other haptic was also enclaved in the same way, and the proper IOL position could be recognized during surgery by confi rming the round shape of the pupil and the proper enclavation sites of both haptics, which could be seen anteriorly. Finally, the viscoelastic device was completely removed and sutures with 10-0 nylon were placed close to the scleral incision.
Transscleral 
RESULTS
No signifi cant differences between the two procedures in mean age and preoperative CDVA (logMAR) (Verisyse: 0.49Ϯ0.46, transscleral suturing group: 0.41Ϯ0.41) were noted. No intraoperative complications occurred in any eyes. Postoperatively, fi ve eyes in the transscleral suturing fi xation group had ciliary choroidal body hemorrhage during follow-up. One eye was diagnosed with cystoid macular edema using fl uorescein angiography, and another eye showed postoperative IOL dislocation resulting in replacement Iris-claw IOL Fixation Without Capsular Support/Hara et al of the IOL by resuturing. In the Verisyse IOL implantation group, no postoperative complications were noted during the observation period ( Table 2) .
VISUAL RECOVERY
No statistically signifi cant changes in CDVA (log-MAR) were noted in the Verisyse IOL group at each examination point before and after surgery (preoperative 0.49Ϯ0.46, 1 day 0.61Ϯ0.39, 1 week 0.41Ϯ0.21, 2 weeks 0.32Ϯ0.21, 1 month 0.35Ϯ0.26, and 6 months 0.28Ϯ0.28). In the transscleral suturing fi xation group, CDVA at postoperative day 1 (0.97Ϯ0.84) was statistically signifi cantly worse than preoperative CDVA (0.41Ϯ0.41) (PϽ.05) and recovered at postoperative week 1 (0.59Ϯ0.33) compared to the preoperative level (Fig 1A) . In the SuperFlex620H IOL implantation subgroup, mean CDVA at postoperative day 1 (0.93Ϯ0.80) was statistically signifi cantly worse than preoperative CDVA (0.43Ϯ0.40) (PϽ.05) and recovered to the preoperative level 1 week postoperatively (0.55Ϯ0.26). In the CP60NS IOL implantation subgroup, mean CDVA at 1 day and 1 week after surgery (1.06Ϯ1.06 and 0.63Ϯ0.42, respectively) were statistically signifi cantly worse than preoperative CDVA (0.35Ϯ0.48) (PϽ.05) and recovered to the preoperative level 2 weeks postoperatively (0.53Ϯ0.52) (Fig 1B) . Figure 1 . A) Changes in mean logMAR corrected distance visual acuity (CDVA) over time in the retropupillary fixation and transscleral suturing fixation groups. In the retropupillary fixation of Verisyse IOL (Abbott Medical Optics) group, mean CDVA showed no significant changes even 1 day postoperatively. In the transscleral suturing IOL group, mean CDVA at postoperative day 1 was significantly worse than preoperative CDVA (PϽ.05). B) Changes in mean CDVA (logMAR) over time for the two subgroups of transscleral suturing fixation. In the SuperFlex620H IOL (Rayner Intraocular Lenses Ltd) subgroup, mean CDVA at postoperative day 1 was statistically significantly worse than preoperative CDVA (PϽ.05) and recovered to the preoperative level at postoperative week 1. In the CP60NS IOL (CORNEAL Laboratoire) subgroup, mean CDVA at 1 day and 1 week after surgery were statistically significantly worse than preoperative CDVA (PϽ.05) and recovered to the preoperative level at postoperative week 2. *PϽ.05 (one-way analysis of variance).
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INTRAOCULAR PRESSURE
Although mean preoperative IOP showed no signifi cant differences between groups (Verisyse IOL 14.8Ϯ2.2 mmHg and transscleral suturing group 13.9Ϯ3.5 mmHg), IOP at postoperative day 1 in the transscleral suturing fi xation group (20.2Ϯ7.4 mmHg) was statistically signifi cantly higher than the Verisyse IOL group at the same time period (13.3Ϯ3.9 mmHg) (P=.0126) (Fig 2) . No signifi cant differences were noted in mean IOP between the Verisyse IOL and transscleral suturing fi xation groups at 1 week (15.2Ϯ5.8 and 14.7Ϯ7.7 mmHg), 2 weeks (14.3Ϯ4.9 and 13.5Ϯ3.7 mmHg), 1 month (16.0Ϯ2.8 and 12.4Ϯ3.4 mmHg), and 6 months (15.5Ϯ2.1 and 13.7Ϯ1.9 mmHg), respectively.
SURGICAL TIME
The mean surgical time in the Verisyse IOL group (20.0Ϯ8.9 min) was signifi cantly shorter than that in the transscleral suturing fi xation group (49.7Ϯ18.9 min) (PϽ.0001) (Fig 3) .
DISCUSSION
Retropupillary fi xation of the Verisyse IOL has been reported to be a promising option for IOL implantation in the posterior chamber without suffi cient capsular support. [23] [24] [25] [26] [27] Baykara et al 24 described that after retropupillary fi xation of the Verisyse IOL, none of 32 eyes showed decompensation, clinically signifi cant pigment dispersion, or secondary glaucoma requiring additional postoperative treatment. In the present study, no postoperative complications occurred in the Verisyse IOL group, whereas ciliary choroidal body hemorrhage was seen in 20% of eyes in the SuperFlex620H IOL and 33% of eyes in the CP60NS IOL implantation groups. Cystoid macular edema and IOL dislocation were seen in 17% of eyes in the CP60NS IOL group. We speculated that the difference between the two types of transscleral suturing IOL was that implantation of the SuperFlex620H IOL was more recently developed as a less invasive transscleral suturing fi xation technique in which the posterior chamber IOL can be implanted in a foldable fashion through a 3.5-mm corneal incision, whereas implantation of the CP60NS IOL requires a 5.5-mm scleral tunnel incision.
Mean CDVA signifi cantly deteriorated 1 day after surgery in the transscleral suturing fi xation group compared with preoperative CDVA. This presumably occurred due to hyphema and ciliary choroidal body hemorrhage that resulted from invasive manipulation around the ciliary choroidal body. Perforation of the ciliary choroidal body, even by needles, can cause considerable stress to the eye. Eyes undergoing retropupillary fi xation of the Verisyse IOL showed no decrease in CDVA 1 day postoperatively. In eyes undergoing implantation of the SuperFlex620H IOL, mean postoperative CDVA recovered to the preoperative level in 1 week. The retropupillary fi xation of the Verisyse IOL showed earlier visual recovery and fewer complications than transscleral suturing fi xation of the posterior chamber IOL.
Mean IOP was higher in the transscleral suturing fi xation group than in the Verisyse IOL group 1 day postoperatively. We suggest that retropupillary fi xation of the Verisyse IOL is not likely to cause secondary glaucoma after surgery, presumably due to the reduced invasion and rare occurrences of hyphema.
Mean surgical time in the Verisyse IOL implantation group was signifi cantly shorter than in the trans- Iris-claw IOL Fixation Without Capsular Support/Hara et al scleral suturing fi xation groups. In transscleral suturing fi xation, surgeons often struggle while searching for adequate fi xation positions for the haptics, scleral fl aps are constructed to hide the knots, and proper vitrectomy is performed to avoid undesirable retinal detachment and ciliary choroidal hemorrhage. Because surgeons can omit these procedures in the retropupillary fi xation of the Verisyse IOL, surgical time could be shortened in comparison with transscleral suturing fi xation.
The present study has several limitations. Intraocular lens position and chronic damage to the iris at fi xation points should be observed for a longer period of time. Although obvious dislocation of the Verisyse IOL and collapse into the vitreous cavity were not observed during a 6-month period in the present study, all patients should be informed of the possibility of dislocation, which can cause deterioration of vision and requires emergency replacement. It is also possible that the irisclaw haptic might release the chronically damaged iris and cause dislocation of the IOL for a long period after surgery. Although there were no eyes with signifi cant corneal endothelial cells loss, dispersion of the iris epithelial pigment, or secondary glaucoma following retropupillary fi xation of the Verisyse IOL in the present study, long-term observation and comparison of corneal endothelial cell density and IOP between two surgical methods with a larger series of cases is necessary.
Because claw-shaped haptics are directly enclaved at the iris plane in the posterior chamber, the Verisyse IOL is fi xated behind the iris with the optic plane parallel to the iris plane. Therefore, theoretically, tilt of the IOL hardly occurs, whereas the sutured fi xation easily causes the IOL to tilt due to a loosened knot. For this reason, evaluation of visual function such as higher order aberration and contrast sensitivity measurements should reveal the effects of tilting.
Retropupillary iris-claw fi xation of the Verisyse IOL at the posterior chamber can be performed less invasively and in a shorter surgical time period with earlier visual recovery after surgery compared to transscleral suturing fi xation of an IOL. This technique is a promising option for posterior chamber IOL implantation for aphakic eyes in the absence of suffi cient capsular support. 
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